I would also point out that anyone who intimates to investors that they must wait until Phase 2b or Phase 3 results to see any kind of spike in share price is also misleading investors.....this stock will act like the countless biotech firms that base themselves on a single product.... their valuations fly upwards or downwards depending on phase testing results.Entremed, as you know ,recently showed that angiostatin and angiotensin shrank tumors in experiments with mice...and the stock skyrocketed .Did anyone care whether the company will have further success?No, they only cared that there was positive data toward the solution of a terrible pathologic process.In the process, the stock went from a low in 1998 of 6 1/2 to 85 in a few days, and has now settled to 33. That's a five bagger in a few weeks after the good news. Naturally, there are many companies that have tanked upon the release of bad data. Entremed is a long way from an approved product, but that did not stop the stock from flying. Investors care about good news NOW, and they react without any reagard for the long term when they are satisfied by the results............I don't claim that Sanguine is another such case-I would be a fool to do so. But I will say that I will see profit in my investment long before this product is fda approved, and that there is certainly precedent for this company to do well before the product is approved...if I seem to be excessively enthusiastic, forgive me . I am not here to hype; I merely point out that this company has a solid product, already tested in humans, that has a better risk to re ward ratio than many drugs that have been fda approved. Think for a moment about chemotherapy agents.These are some of the most horrendous poisons you can legally put into your body. Forthright, go look up drugs such as Immuran, Cis-platinum, Cytoxan,vincristine,,methotrexate,and so on. A Physician's Desk Reference will do.Check out the side effects profile of these drugs. The known side effects of Fluosol(active ingredient identical to Pher02) are a cakewalk compared to these drugs.....yet the fda approved all these drugs.Why? Because without them, people were dropping dead from cancer without a chance. The side effects were deemed to be okay enough for the chance it gave people to survive cancer.You don't think that there are carloads of people dying around the world because they dont have access to blood products? Do you think that there won't be excitement when Pher02 is found to be effective and not toxic enough to do more harm than good? Do you believe that the approval risk for this drug is the same or worse than that of the above-mentioned chemo agents? Not likely, according to the human trials done with Fluosol to date.Again Fluosol and Pher02 share the identical active ingredient.
Please stop creating the impression that no one will see profit from this stock for years, or that approval is to be an unlikely process. You and I both know better.
Tell us about the companies and products in which you have been involved, and let us know what leads you to beleve that Pher02 has a difficult, long road ahead.
|
